C4 Therapeutics, Inc. (CCCC) vs Opus Genetics, Inc. (IRD)
- C4 Therapeutics, Inc. CCCC 2.77 −0.36%
- Opus Genetics, Inc. IRD 3.81 −5.93%
C4 Therapeutics, Inc. and Opus Genetics, Inc. are both Biotechnology companies. C4 Therapeutics, Inc. and Opus Genetics, Inc. are of similar size ($342.0M and $336.9M). C4 Therapeutics, Inc. grew revenue faster over the last twelve months: 2.33% against −36.1%. C4 Therapeutics, Inc. has the higher net margin (−289.4% vs −1,091.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, C4 Therapeutics, Inc. leads on 8 and Opus Genetics, Inc. on 6.
Valuation
Profitability
| Metric | CCCC | IRD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (318.97%) | (513.47%) | 0.00% |
| Net margin | (289.44%) | (1,091.82%) | 0.00% |
| Free cash flow margin | (243.71%) | (412.61%) | 0.00% |
| Return on equity | (48.14%) | (4,796.52%) | (56.36%) |
| Return on assets | (30.92%) | (163.50%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack